When differentiating smooth muscle tumors from LG-ESS, a combined panel of high-sensitivity markers with specific markers (such as h-caldesmon, transgelin, and, potentially, smoothelin) is recommended, keeping in mind that α-SMA and desmin in particular do not serve as good discriminators between endometrial stromal and smooth muscle lineage. This evidence concerns the gene SMTN and smooth muscle tumor.